Work

Phase II study of DHA-paclitaxel (TXP) as first line chemotherapy in patients with hormone refractory prostate cancer (HRPC)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.4657

Authors: R. Bellet, M. Carducci, D. Petrylak, B. Kasimis, D. Irwin, M. Modiano, R. Mansour, R. Axelrod, M. Doukas

Institutions: University of Kentucky, Johns Hopkins University, Thomas Jefferson University Hospital, East Orange VA Medical Center, Feist-Weiller Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604753393

Cites:

Cited by: 7

Related to: 10